Skip to Main Content

Elizabeth Claus, PhD, MD

Professor of Biostatistics; Director of Medical Research, School of Public Health



Elizabeth B. Claus, MD, PhD is Professor and Director of Medical Research in the Yale University School of Public Health as well as Attending Neurosurgeon and Director of Stereotactic Radiosurgery within the Department of Neurosurgery at Brigham and Women’s Hospital in Boston. She is a member of the board of advisors for the Acoustic Neuroma Association (ANA) as well as the Central Brain Tumor Registry of the United States (CBTRUS). Dr. Claus' work is focused in cancer and genetic epidemiology with an emphasis on the development of risk models for breast and brain tumors. She is the overall PI of the Meningioma Consortium, the Meningioma Genome-Wide Association Study, and the Yale Acoustic Neuroma Study as well as a co-investigator of the GLIOGENE (Genes for Glioma) and International Glioma Case/Control (GICC) projects. In addition to her research activities, Dr. Claus is a Board-certified neurosurgeon who completed her residency in neurosurgery at Yale-New Haven Hospital and her fellowship in neurosurgical oncology at Brigham and Women’s Hospital. Her clinical focus is on the treatment of meningioma, glioma, acoustic neuroma and brain metastases. In partnership with national patient brain tumor organizations including the American Brain Tumor Association (ABTA), the National Brain Tumor Society (NBTS) and the ANA, Dr. Claus is working to develop cost- and time-efficient web- and smartphone- based recruitment strategies to be used in the study of brain tumors. She has developed such work in collaboration with the ANA and recently received pilot funding from the ABTA/NBTS to commence development of a web-based registry for patients with low grade glioma in an effort to advance research efforts for this group of patients.

Education & Training

  • Fellow
    Brigham and Women's Hospital (2003)
  • Resident
    Yale-New Haven Hospital (2002)
  • Resident
    Yale- New Haven Hospital (1996)
  • MD
    Yale University School of Medicine (1994)
  • PhD
    Yale University (1988)


  • Glioma Research Consortium
    Denmark; United Kingdom; Israel; Sweden; United States 2008
    Professor Claus is a co-investigator for GLIOGENE, an international, multidisciplinary consortium of glioma researchers. The goal of this consortium is to identify susceptibility genes in high-risk familial brain tumor pedigrees by screening glioma patients within the United States, Europe, and Israel. The hypothesis is that there are specific discoverable genotypes that increase the risk of developing brain tumors. Professor Claus also conducts work with this group to refine treatment algorithms for patients diagnosed with low-grade gliomas.
  • Clinical Neurosurgery
    Boston, United States 2002
    Dr. Claus practices neurosurgery at Brigham and Women's Hospital

Honors & Recognition

AwardAwarding OrganizationDate
Top 100 Publications, Yale CentennialSchool of Public Health, Yale University2015

Professional Service

Acoustic Neuroma AssociationTo advise the ANA on a variety of topics related to the occurrence and treatment of acoustic neuroma2010 - 2015
National Institutes of HealthProvide advice to NIH relative to the Cancer Post-GWAS Initiative2010 - Present

Departments & Organizations